Tech Company Financing Transactions

Peptilogics Funding Round

Founders Fund, private investors and Presight Capital participated in a $78 million Series B funding round for Peptilogics. The round was announced by the company on 10/16/2025.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

2730 Sidney St. 300
Pittsburgh, PA 15203
USA

Phone

Undisclosed

Website

www.peptilogics.com

Email Address

[email protected]

Overview

Peptilogics is an early-stage biotechnology company utilizing an innovative platform technology which enables us to rapidly and effectively develop novel peptide therapeutics, with a focus on antibiotics. Our pipeline includes a novel class of engineered Cationic Antimicrobial Peptides (eCAPs).

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Sanjay Kakkar

        

Chief Medical Officer

Todd Lorenz

        

Chief Scientific Officer

Jonathan Steckbeck

        

Browse more venture capital transactions:

Prev: 10/16/2025: Strella venture capital transaction
Next: 10/16/2025: BridGene Biosciences venture capital transaction

Share this article

About Our VC Transactions Data

We do our best to record funding rounds that are announced publicly. VC investment data records reported here are derived from company press releases and news coverage. The data is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary